Alere Inc. (ALR)


NYSE - NYSE Real Time Price. Currency in USD
39.31-0.04 (-0.10%)
At close: 4:02 PM EDT
People also watch:
BIOHOLXHAEDXCMCRL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open39.13
Prev Close39.35
Bid39.30 x 300
Ask39.32 x 300
Day's Range38.99 - 39.60
52wk Range31.47 - 54.79
1y Target EstN/A
Market Cap3.41B
P/E Ratio (ttm)-95.41
Beta-0.29
Volume702,025
Avg Vol (3m)1,019,264
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals9 hours ago

    Alere sues Abbott to complete $5.8B merger

    Shares of Waltham-based diagnostics firm Alere are down days after the company issued a statement saying it’s suing the company it’s hoping to merge with, Abbott Laboratories. Alere's shares fell about 4 percent Friday, and have stayed there for the following two days, giving the company a market capitalization of $3.4 billion. Illinois-based Abbott (ABT) announced an agreement to buy Alere on Feb. 1 for $5.8 billion, but the deal quickly ran into problems.

  • Zacksyesterday

    Stock Market News for August 29, 2016

    Benchmarks ended a choppy trading session mostly in the red on Friday as investors continued to grapple with the timing of a rate hike

  • Abbott Labs Sued by Alere over Pending $5.8B Acquisition
    Zacksyesterday

    Abbott Labs Sued by Alere over Pending $5.8B Acquisition

    Abbott Labs (ABT) was sued by Alere (ALR) in the latter's attempt to force the former to complete the $5.8 billion takeover.